INFARMED
0437.680.232 · rovalta.com · 09/11/2026
INFARMED
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOINFARMED is a Private limited company incorporated in 1989. Its main activity is: Pre-primary education. Its registered office is in Alken.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0437.680.232
- Incorporation
- 21/06/1989
- Legal form
- Private limited company
- Registered office
- Stationsstraat 27
3570 Alken · FlandreSee on map - Contributed capital
- 7 436,80 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 7 k € | -76.4% | 29,6 k € | +30.0% | 22,7 k € | -56.8% | 52,7 k € | +22.6% | 43 k € |
| EBITDA | 4,3 k € | -83.2% | 25,6 k € | +32.9% | 19,3 k € | -61.1% | 49,6 k € | +28.8% | 38,5 k € |
| Operating result | -6,9 k € | -148% | 14,4 k € | +2250% | -672 € | -102% | 29,7 k € | +49.7% | 19,8 k € |
| Net result | -9,1 k € | -222% | 7,4 k € | +189% | -8,4 k € | -150% | 16,7 k € | +332% | -7,2 k € |
| Balance sheet | |||||||||
| Equity | 276,8 k € | -3.2% | 285,8 k € | +2.7% | 278,4 k € | -2.9% | 286,8 k € | +6.2% | 270,1 k € |
| Total assets | 387,3 k € | -1.7% | 393,9 k € | -26.7% | 537,3 k € | -10.9% | 602,8 k € | -4.1% | 628,4 k € |
| Cash | 53 k € | +9.3% | 48,5 k € | +266% | 13,2 k € | -77.8% | 59,6 k € | -17.3% | 72,1 k € |
| Debts | 101,2 k € | -0.4% | 101,7 k € | -60.0% | 253,9 k € | -18.7% | 312,3 k € | -12.1% | 355,1 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Noëlla Heyman | Directorsince 18/03/1991Manager2018 accountsended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 18/05/2026 | 18/08/2025 | 16/07/2024 | 20/06/2023 | 07/07/2022 | 02/06/2021 |
| General meeting | 13/05/2026 | 30/06/2025 | 26/06/2024 | 14/06/2023 | 15/06/2022 | 12/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 13/05/2026 | 18/05/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 18/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 26/06/2024 | 16/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 14/06/2023 | 20/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 15/06/2022 | 07/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 12/05/2021 | 02/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 13/05/2020 | 10/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 17/06/2019 | 10/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 15/06/2018 | 13/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 31/05/2017 | 11/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 29/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 24/06/2015 | 14/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 14/05/2014 | 30/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 08/05/2013 | 19/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 09/05/2012 | 20/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 04/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 12/05/2010 | 05/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 13/05/2009 | 29/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 14/05/2008 | 27/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 09/05/2007 | 20/08/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Noëlla Heyman | Directorsince 18/03/1991Manager2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Stationsstraat 27, 3570 AlkenCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00114756 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| INFARMEDCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00114756 |
Events
- 2025Annual accounts 2025-9,1 k €↓
- 2024Annual accounts 20247,4 k €↑
- 2023Annual accounts 2023-8,4 k €↓
- 2022Annual accounts 202216,7 k €↑
- 2021Annual accounts 2021-7,2 k €↓
- 2020Annual accounts 20204 k €↓
- 2019Annual accounts 201929,1 k €↓
- 2018Annual accounts 201868,6 k €↑
- 2017Annual accounts 201746,1 k €↓
- 2016Annual accounts 201667,3 k €↑
- 2015Annual accounts 201545,5 k €↑
- 2014Annual accounts 2014-10,2 k €↑
- 2013Annual accounts 2013-30,8 k €↑
- 2012Annual accounts 2012-67,7 k €↓
- 2011Annual accounts 20119 k €↓
- 2010Annual accounts 201064,6 k €↑
- 2009Annual accounts 200923,2 k €↓
- 2008Annual accounts 200876,3 k €↑
- 2007Annual accounts 200755 k €↑
- 2006Annual accounts 200648,9 k €
- 21/06/1989IncorporationPrivate limited company